Core Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	67.24	101.93	112.07	242.52	327.56	54.19
Other Revenue	266.94	408.74	390.33	397.8	216.93	6.13
Revenue	334.18	510.67	502.4	640.31	544.48	60.32
Revenue Growth (YoY)	-40.08%	1.65%	-21.54%	17.60%	802.66%	1.34%
Cost of Revenue	300.05	377.37	378.94	631.91	305.62	50.93
Gross Profit	34.14	133.3	123.46	8.4	238.86	9.39
Selling, General & Admin	204.89	132.65	100.93	223.71	64.55	16.33
Research & Development	11.83	11.83	7.18	26.96	7.67	5.27
Other Operating Expenses	-26.5	3.81	4.43	187.02	32.39	-0.07
Operating Expenses	190.22	148.29	112.54	437.69	104.61	21.53
Operating Income	-156.08	-14.99	10.92	-429.29	134.25	-12.14
Interest Expense	-15.4	-37.07	-86.24	-96.83	-44.35	-4.44
Currency Exchange Gain (Loss)	-4.21	-4.21	-1.96	-28.03	-0.12	-0
Other Non Operating Income (Expenses)	-586.85	-1,369	2.53	42.2	-0	-0.11
EBT Excluding Unusual Items	-744.08	-1,425	-74.75	-511.94	89.77	-16.69
Merger & Restructuring Charges	-5.51	-	-	-6.8	-	-
Impairment of Goodwill	-	-	-	-1,055	-	-
Asset Writedown	-	-	-	-590.74	-	-
Legal Settlements	-13.43	-	-	-	-2.64	5.81
Other Unusual Items	-1.38	110.95	-171.06	0.77	-24.06	-1.33
Pretax Income	-767.44	-1,314	-245.8	-2,163	63.08	-12.21
Income Tax Expense	0.86	0.86	0.68	-17.09	15.76	-
Net Income	-768.31	-1,315	-246.49	-2,146	47.31	-12.21
Preferred Dividends & Other Adjustments	-114.06	-192.59	-	-	-	10.48
Net Income to Common	-654.25	-1,122	-246.49	-2,146	47.31	-22.68
Shares Outstanding (Basic)	304	256	380	341	207	158
Shares Outstanding (Diluted)	304	256	380	341	233	158
Shares Change (YoY)	6.29%	-32.65%	11.51%	46.01%	48.03%	59.70%
EPS (Basic)	-2.15	-4.39	-0.65	-6.30	0.23	-0.14
EPS (Diluted)	-2.15	-4.39	-0.65	-6.30	0.20	-0.14
Free Cash Flow	-343.97	-52.07	48.95	-396.47	-56.74	-25.33
Free Cash Flow Per Share	-1.13	-0.20	0.13	-1.16	-0.24	-0.16
Gross Margin	10.21%	26.10%	24.57%	1.31%	43.87%	15.57%
Operating Margin	-46.71%	-2.94%	2.17%	-67.04%	24.66%	-20.12%
Profit Margin	-195.78%	-219.79%	-49.06%	-335.20%	8.69%	-37.61%
Free Cash Flow Margin	-102.93%	-10.20%	9.74%	-61.92%	-10.42%	-42.00%
EBITDA	-75.23	98.22	106.92	-204.03	167.61	-2.74
EBITDA Margin	-22.51%	19.23%	21.28%	-31.86%	30.78%	-4.54%
D&A For EBITDA	80.86	113.21	96	225.26	33.36	9.4
EBIT	-156.08	-14.99	10.92	-429.29	134.25	-12.14
EBIT Margin	-46.71%	-2.93%	2.17%	-67.04%	24.66%	-20.12%
Effective Tax Rate	-	-	-	-	24.99%	-
Revenue as Reported	334.18	510.67	502.4	640.31	544.48	60.32

Updated Oct 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q